February 2019 Briefing - Dermatology
Here are what the editors at HealthDay consider to be the most important developments in Dermatology for February 2019. This roundup includes the latest research news from journal articles, as well as the FDA approvals and regulatory changes that are the most likely to affect clinical practice.
Tumor Control Durable With Pembrolizumab in Merkel Cell Cancer
WEDNESDAY, Feb. 27, 2019 (HealthDay News) -- For patients with advanced Merkel cell carcinoma (aMCC), pembrolizumab is associated with durable tumor control and favorable overall survival, according to a study published online Feb. 7 in the Journal of Clinical Oncology.
2014 to 2017 Saw Improvement in Burnout for U.S. Physicians
MONDAY, Feb. 25, 2019 (HealthDay News) -- From 2014 to 2017, there was an improvement in burnout and satisfaction with work-life integration among U.S. physicians, according to a study published online Feb. 22 in the Mayo Clinic Proceedings.
National Health Spending Set to Increase 5.5 Percent Annually
FRIDAY, Feb. 22, 2019 (HealthDay News) -- National health spending is projected to increase at an annual rate of 5.5. percent from 2018 to 2027, with fundamental economic and demographic factors the main drivers, according to a report published online Feb. 20 in Health Affairs.
Most Patients Do Not Disclose Complementary Medicine Use
FRIDAY, Feb. 22, 2019 (HealthDay News) -- Just one-third of users of biologically based complementary medicine (CM) disclose their use to traditional health care providers, according to a review published online Feb. 7 in Scientific Reports.
Guideline Covers Extracutaneous Manifestations of Psoriasis
FRIDAY, Feb. 22, 2019 (HealthDay News) -- The extracutaneous manifestations of psoriasis and guidance on use of biologic treatment for management of psoriasis are discussed in two new guidelines published online Feb. 13 in the Journal of the American Academy of Dermatology.
FDA Advances Regulation to Ensure Sunscreen Safety, Efficacy
THURSDAY, Feb. 21, 2019 (HealthDay News) -- The U.S. Food and Drug Administration took steps Thursday to tighten regulation of over-the-counter sunscreen products.
Vertical Integration Has Little Impact on Quality Measures
THURSDAY, Feb. 21, 2019 (HealthDay News) -- Vertical integration between hospitals and physicians has little impact on quality measures, while increased hospital market concentration is strongly associated with reduced quality in measures of patient satisfaction, according to a study published online Feb. 9 in Medical Care Research and Review.
New Kaiser Permanente Medical School Plans to Waive Tuition
WEDNESDAY, Feb. 20, 2019 (HealthDay News) -- A new medical school to be opened by California-based health system Kaiser Permanente will waive tuition for all students in its first five graduating classes.
Hospital Prices Growing Faster Than Physician Prices
FRIDAY, Feb. 15, 2019 (HealthDay News) -- Growth in hospital prices and payments outpaced growth in physician prices and payments from 2007 through 2014, according to a report published in the February issue of Health Affairs.
Health Care Spending Per Person Increased to $5,641 in 2017
TUESDAY, Feb. 12, 2019 (HealthDay News) -- In 2017, health care spending per person reached $5,641, according to the Health Care Cost Institute (HCCI) annual Health Care Cost and Utilization Report.
Many Systematic Reviews Do Not Fully Report Adverse Events
TUESDAY, Feb. 12, 2019 (HealthDay News) -- Many systematic review protocols in the International Prospective Register of Systematic Reviews (PROSPERO) do not include adverse event reporting, according to a study published in the April issue of the Journal of Clinical Epidemiology.
Acne Relapses Linked to Lower Quality of Life, Productivity
TUESDAY, Feb. 12, 2019 (HealthDay News) -- Acne relapses are significantly associated with impaired quality of life as well as productivity loss and absenteeism, according to a study recently published in the Journal of the European Academy of Dermatology and Venereology.
Johnson & Johnson to Provide Drug Prices in TV Ads
FRIDAY, Feb. 8, 2019 (HealthDay News) -- In a drug industry first, Johnson & Johnson will start giving the list prices of its prescription drugs in television ads.
Measles Outbreak Triggers Sharp Rise in Demand for Vaccine
FRIDAY, Feb. 8, 2019 (HealthDay News) -- Health clinics in Clark County, Washington, are scrambling to meet the sharply increased demand for measles vaccination as people seek protection during an outbreak of the highly contagious virus.
Psoriasis Tx Linked to Drop in Noncalcified Coronary Plaque
WEDNESDAY, Feb. 6, 2019 (HealthDay News) -- Treatment of psoriasis with biologic therapy is associated with a reduction in noncalcified coronary plaque and improved plaque morphology, according to a study published online Feb. 5 in Cardiovascular Research.
Washington State Measles Cases Now at 48 Since Jan. 1
MONDAY, Feb. 4, 2019 (HealthDay News) -- There have been 48 confirmed cases of measles in Washington state since the start of the year as health officials struggle to stop the spread of the infectious disease.